ENVESTNET ASSET MANAGEMENT INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$778,389
+43.2%
16,925
+79.0%
0.00%
Q2 2023$543,494
+59.7%
9,457
+4.2%
0.00%
Q1 2023$340,388
+61.3%
9,077
+50.0%
0.00%
Q2 2022$211,000
-11.3%
6,053
-8.6%
0.00%
Q1 2022$238,000
+4660.0%
6,621
+2527.4%
0.00%
Q2 2017$5,000
+25.0%
252
-6.7%
0.00%
Q1 2017$4,0000.0%270
+39.9%
0.00%
Q4 2016$4,000
-97.4%
193
-98.0%
0.00%
-100.0%
Q2 2016$155,000
+34.8%
9,6220.0%0.00%
Q1 2016$115,0009,6220.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders